SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-18-010603
Filing Date
2018-07-30
Accepted
2018-07-27 19:13:15
Documents
8
Period of Report
2018-07-27
Effectiveness Date
2018-07-30

Document Format Files

Seq Description Document Type Size
1 def14a.htm DEF 14A 678926
2 img_001.jpg GRAPHIC 6229
3 img_002.jpg GRAPHIC 2460
4 img_003.jpg GRAPHIC 6486
5 img_004.jpg GRAPHIC 2610
6 img_005.jpg GRAPHIC 2580
7 image_001.jpg GRAPHIC 140015
8 image_002.jpg GRAPHIC 110836
  Complete submission text file 0001493152-18-010603.txt   1054259
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37648 | Film No.: 18975820
SIC: 2835 In Vitro & In Vivo Diagnostic Substances